title: A new standard of care? Studies on febuxostat in the management of hyperuricemia with and without gout.
authors.affiliation: Center for Genomic Medicine, RIKEN, 2 Suehiro-cho, Tsurumi-ku, Yokohama, Kanagawa, Japan. kamatani@msb.biglobe.ne.jp
authors.forename: Naoyuki
authors.initials: N
authors.lastname: Kamatani
authors.forename: Kamatani
authors.initials: K
authors.lastname: Naoyuki
authors.forename: Tatsuo
authors.initials: T
authors.lastname: Hosoya
authors.forename: Hosoya
authors.initials: H
authors.lastname: Tatsuo
mesh_terms: D000069465:Febuxostat; D006073:Gout / Q000097:blood / Q000150:complications* / Q000188:drug therapy; D006074:Gout Suppressants / Q000627:therapeutic use*; D006801:Humans; D033461:Hyperuricemia / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D011320:Primary Health Care / Q000592:standards*; D013844:Thiazoles / Q000627:therapeutic use*; D016896:Treatment Outcome; D014527:Uric Acid / Q000097:blood*; D014969:Xanthine Oxidase / Q000037:antagonists & inhibitors
chemical_list: D006074:Gout Suppressants; D013844:Thiazoles; D000069465:Febuxostat; D014527:Uric Acid; D014969:Xanthine Oxidase